[1] Sutton C. Hysteroscopic surgery. Best Practice & Research: Clinical Obstetrics & Gynaecology. 2006; 20: 105-137.

[2] Giannella L, Mfuta K, Cerami LB, Boselli F. Does uterine position affect pain intensity during outpatient diagnostic hysteroscopy? Clinical and Experimental Obstetrics & Gynecology. 2019; 46: 787-791.

[3] Pellicano M, Guida M, Zullo F, Lavitola G, Cirillo D, Nappi C. Carbon dioxide versus normal saline as a uterine distension medium for diagnostic vaginoscopic hysteroscopy in infertile patients: a prospective, randomized, multicenter study. Fertility and Sterility. 2003; 79: 418-421.

[4] Rullo S, Sorrenti G, Marziali M, Ermini B, Sesti F, Piccione E. Office hysteroscopy: comparison of 2.7- and 4-mm hysteroscopes for acceptability, feasibility and diagnostic accuracy. The Journal of Reproductive Medicine. 2005; 50: 45-48.

[5] Floris S, Piras B, Orrù M, Silvetti E, Tusconi A, Melis F, et al. Efficacy of intravenous tramadol treatment for reducing pain during office diagnostic hysteroscopy. Fertility and Sterility. 2007; 87: 147-151.

[6] Unfried G, Wieser F, Albrecht A, Kaider A, Nagele F. Flexible versus rigid endoscopes for outpatient hysteroscopy: a prospective randomized clinical trial. Human Reproduction. 2001; 16: 168-171.

[7] Garbin O, Kutnahorsky R, Göllner JL, Vayssiere C. Vaginoscopic versus conventional approaches to outpatient diagnostic hysteroscopy: a two-centre randomized prospective study. Human Reproduction (Oxford, England). 2007; 21: 2996-3000.

[8] El-Mazny A, Abou-Salem N. A double-blind randomized controlled trial of vaginal misoprostol for cervical priming before outpatient hysteroscopy. Fertility and Sterility. 2011; 96: 962-965.

[9] de Carvalho Schettini JA, Ramos de Amorim MM, Ribeiro Costa AA, Albuquerque Neto LC. Pain evaluation in outpatients undergoing diagnostic anesthesia-free hysteroscopy in a teaching hospital: a cohort study. Journal of Minimally Invasive Gynecology. 2007; 14: 729-735.

[10] de Carvalho Schettini JA, Ramos de Amorim MM, Ribeiro Costa AA, Albuquerque Neto LC. Pain evaluation in outpatients undergoing diagnostic anesthesia-free hysteroscopy in a teaching hospital: a cohort study. Journal of Minimally Invasive Gynecology. 2007; 14: 729-735.

[11] de Freitas Fonseca M, Sessa FV, Resende JAD, Guerra CGS, Andrade CM, Crispi CP. Identifying predictors of unacceptable pain at office hysteroscopy. Journal of Minimally Invasive Gynecology. 2014; 21: 586-591.

[12] Chudnoff S, Einstein M, Levie M. Paracervical block efficacy in office hysteroscopic sterilization: a randomized controlled trial. Obstetrics and Gynecology. 2010; 115: 26-34.

[13] Hassan L, Gannon MJ. Anaesthesia and analgesia for ambulatory hysteroscopic surgery. Best Practice & Research: Clinical Obstetrics & Gynaecology. 2006; 19: 681-691.

[14] Kapila A, Glass PS, Jacobs JR, Muir KT, Hermann DJ, Shiraishi M, et al. Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology. 1995; 83: 968-975.

[15] Dilger JA, Sprung J, Maurer W, Tetzlaff J. Remifentanil provides better analgesia than alfentanil during breast biopsy surgery under monitored anesthesia care. Canadian Journal of Anesthesia. 2004; 51: 20-24.

[16] de Carvalho Schettini JA, Ramos de Amorim MM, Ribeiro Costa AA, Albuquerque Neto LC. Pain evaluation in outpatients undergoing diagnostic anesthesia-free hysteroscopy in a teaching hospital: a cohort study. Journal of Minimally Invasive Gynecology. 2007; 14: 729-735.

[17] Rosow CE. An overview of remifentanil. Anesthesia & Analgesia. 1999; 89: 1.

[18] Servin F, Desmonts JM, Watkins WD. Remifentanil as an analgesic adjunct in local/regional anesthesia and in monitored anesthesia care. Anesthesia & Analgesia. 1999; 89: 28.

[19] Gold M, Watkins W Sung Y, Yarmush J, Chung F, Uy N, et al. Remifentanil versus remifentanil/midazolam for ambulatory surgery during monitored anesthesia care. Anesthesiology. 1997; 87: 51-57.